Henry Schein (Henry Schein) ROCE % : 2.20% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Henry Schein ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Henry Schein's annualized ROCE % for the quarter that ended in Dec. 2023 was 2.20%.

Henry Schein ROCE % Historical Data

The historical data trend for Henry Schein's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henry Schein ROCE % Chart

Henry Schein Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

14.07

10.21

14.71

12.04

8.81

Henry Schein Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															4.70	11.08	12.36	11.19	2.20

Henry Schein ROCE % Calculation

Henry Schein's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	629	/	( ( (8607 - 2224)	+	(10573 - 2683) )	/ 2 )
	=	629	/	( (6383	+	7890)	/ 2 )
	=	629	/	7136.5
	=	8.81 %

Henry Schein's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	172	/	( ( (9810 - 2093)	+	(10573 - 2683) )	/ 2 )
	=	172	/	( ( 7717	+	7890 )	/ 2 )
	=	172	/	7803.5
	=	2.20 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Henry Schein (NAS:HSIC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Henry Schein ROCE % Related Terms

Thank you for viewing the detailed overview of Henry Schein's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Henry Schein (Henry Schein) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Henry Schein Inc (NAS:HSIC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

HS2:Germany

Address

135 Duryea Road, Melville, NY, USA, 11747

Website

https://www.henryschein.com

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.

Executives

Stanley M Bergman	director, officer: President and CEO	C/O HENRY SCHEIN INC, 135 DURYEA ROAD, MELVILLE NY 11747
Bradford C Connett	officer: CEO, NA Distribution Group	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Brous David B Jr	officer: CEO, Strategic Business Group	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Walter Siegel	officer: Senior VP & General Counsel	C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
James P Breslawski	director, officer: Executive Vice President	C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Michael S Ettinger	officer: SVP, General Counsel, Sec.	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Mark E Mlotek	director, officer: SVP, Corp Bus Dev Group	C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Lorelei Mcglynn	officer: SVP, Global HR & Fin. Oper.	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Gerald A Benjamin	director, officer: Executive V.P and CAO	C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
Ronald N. South	officer: SVP & Chief Financial Officer	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Philip A Laskawy	director	9 CREAMER HILL ROAD, GREENWICH CT 06831
Kurt P Kuehn	director	C/O HENRY SCHEIN, INC, 135 DURYEA ROAD, MELVILLE NY 11747
Scott Philip Serota	director	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Reed Vaughn Tuckson	director	C/O UNITEDHEALTH GROUP INCORPORATED, 9900 BREN ROAD EAST, MINNETONKA MN 55123
Steven Paladino	director, officer: Executive V.P. and CFO	C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747